Zhou Yiqing | |
---|---|
周义清 | |
Born | 1929 (age 94–95) |
Nationality | Chinese |
Citizenship | People's Republic of China |
Education | PLA Second Military Medical University |
Known for | Invention of Coartem |
Awards | European Inventor Award (2009) |
Scientific career | |
Fields | Medicine |
Institutions | Eighth Route Army Institute of Microbiology and Epidemiology of the People's Liberation Army Academy of Military Medical Sciences |
Zhou Yiqing (born 1929) is a professor of medicine at the Institute of Microbiology and Epidemiology of the People's Liberation Army Academy of Military Medical Sciences.[1] He was one of the scientists who participated in the Project 523 of the Chinese Government under Chairman Mao Zedong. The project resulted in the discovery of artemisinins, a class of antimalarial drugs, from the medicinal plant Artemisia annua.[2][3]
Zhou specifically worked on artemether, one of the derivatives of artemisinin. In 1985 he combined artemether with another drug lumefantrine into a single tablet, which he successfully used for the treatment of severe malaria. With the support of Novartis, the drug was produced in 1991 under the brand name Coartem, and it became the first artemisinin-based combination therapy.[4] For this invention he and his team were awarded the European Inventor Award of 2009 in the category "Non-European countries".[5]